Alembic Pharma receives USFDA final approval for doxycycline capsules, with US sales of $123 million.

#Nifty #Nifty50 #banknifty #niftybank #Dow #SP500 #Nasdaq #stockmarket #Bitcoin     #zerodha #stocks
#Nifty #Nifty50 #banknifty #niftybank #Dow #SP500 #Nasdaq #stockmarket #Bitcoin #zerodha #stocks